Anti-gal antibody-mediated allograft rejection in α1,3- galactosyltransferase gene knockout mice: A model of delayed xenograft rejection

Transplantation

Volumn 66, Issue 6, 1998, Pages 748-754

  Pearse, Martin J ^a   Witort, Ewa ^a   Mottram, Patricia ^b   Han, Wenruo ^b   Murray Segal, Lisa ^b   Romanella, Margarita ^a   Salvaris, Evelyn ^a   Shinkel, T A ^a   Goodman, David J ^a   D'Apice, Anthony J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLTRANSFERASE;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; GRAFT VERSUS HOST REACTION; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; ANTIBODIES, PROTOZOAN; DISACCHARIDES; FEMALE; GALACTOSYLTRANSFERASES; GRAFT REJECTION; HEART TRANSPLANTATION; LEISHMANIA MAJOR; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYOCARDIUM; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032572979     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199809270-00009     Document Type: Article

References (32)

1. Galili U, Shohet SB, Korbin E, Stults CLM, Macher BA. Man, apes and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755.
2. Sandrin MS, Vaughan HA, Dabkowski PL, Mckenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal(α1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
3. Cooper DKC, Good AH, Koren E, et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993; 1: 198.
4. Galili U, Swanson K. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 1991; 88: 7401.
5. Galili U, Mandrell RE, Hamedeh RM, Shohet SB, Griffiths JMcL. Interaction between natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Immun Infect 1988; 56: 1730.
6. Neethling FA, Koren E, Ye Y, et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides. Transplantation 1994; 57: 959.
7. Vaughan HA, Loveland BE, Sandrin MS. Galα(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies. Transplantation 1994; 58: 879.
8. Tearle RG, Tange MJ, Zannettino ZL, et al. The α-1,3-galactosyltransferase knockout mouse: implications for xenotransplantation. Transplantation 1996; 61: 13.
9. Tange MJ, Tearle RG, Aminian A, et al. Demonstration of the functional importance of the Gal epitope in an ex vivo model of xenotransplantation. Xenotransplantation 1997; 4: 20.
10. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1(12): 1261.
11. Chen C-G, Fisicaro N, Shinkel TA, et al. Reduction in Gal-α 1,3-Gal epitope expression in transgenic mice expressing human H-transferase. Xenotransplantation 1996; 3: 69.
12. Koike C, Kannagi R, Takuma Y, et al. Introduction of α(1,2)-fucosyltransferase and its effect on α-Gal epitopes in transgenic pig. Xenotransplantation 1996; 3: 81.
13. Sharma A, Okabe J, Birch P, et al. Reduction in the level of Gal(α1,3)Gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190.
14. Blakely ML, Vanderwerf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
15. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
16. Galili U, LaTemple DC, Walgenbach AW, Stone KR. Porcine and bovine cartilage transplants in cynomolgus monkey. II. Changes in anti-Gal response during chronic rejection. Transplantation 1997; 63: 646.
17. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG. Increased anti-Gal activity in diabetic patients transplanted with porcine islet cells. Transplant Proc 1996; 28: 564.
18. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
19. Schraa EO, Schotman SN, Scheringa M, Daha MR, Marquet RL, Ijzermans JNM. Discordant liver transplantation in the guinea pig to rat model does not lead to classical hyperacute rejection. Xenotransplantation 1996; 3: 321.
20. Harrison RA, Lachman PJ. Handbook of experimental immunology and immunochemistry. Oxford: Blackwell Scientific Publications, 1986.
21. Mottram PL, Mirisklavos A, Dumble LJ, Clunie GJA. T suppressor cells induced by transfusions and cyclosporine A: studies in the mouse cardiac allograft model. Transplantation 1990; 50: 1033.
22. Oriol R, Cooper DK. Major carbohydrate xenotransplantation antigens. In: Cooper DK, Kemp E, Platt JL, White DJ, eds. Xenotransplantation. Berlin: Springer, 1997: 24.
23. Thall AD, Murphy HS, Lowe JB. α1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant Proc 1996; 28: 556.
24. Avila JL, Rojas M, Galili U. Immunogenic Galα1-3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J Immunol 1989; 142: 2828.
25. Lesnikoski BA, Shaffer DA, Vanderwerf WJ, et al. Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to-baboon discordant xenografts. Transplant Proc 1995; 27: 290.
26. Azimzadeh A, Wolf P, Dalmasso AP, et al. Assessment of hyperacute rejection in a rat-to-primate cardiac xenograft model. Transplantation 1996; 61: 1305.
27. Dabkowski PL, Vaughan HA, Mckenzie IFC, Sandrin MS. Characterisation of a cDNA clone encoding the pig α1,3-galactosyltransferase: implications for xenotransplantation. Transplant Proc 1993; 25: 2921.
28. Candinas D, Lesnikoski BA, Robson SC, et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 1996; 62: 336.
29. Fryer JP, Chen S, Johnson E, et al. The role of monocytes and macrophages in delayed xenograft rejection. Xenotransplantation 1997; 4: 40.
30. Leventhal JR, Matas AJ, Sun LH, Reif SA, Bolman RM III, Platt JL. The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation 1993; 56: 1.
31. Bach FH, Turman MA, Vercellotti GM, Platt JL, Dalmasso AP. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991; 23: 205.
32. Chen C-G, Salvaris EJ, Romanella M, et al. Transgenic expression of human α1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 832.